glp-1 drug mounjaro Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort Is Mounjaro the Same as
Description
Glucagonlike peptide agonists for weight management in antipsychoticinduced weight gain: a systematic review and metaanalysis
3 however, there is still a lack of understanding about drug therapy
Participants with class III obesity (BMI 40 or higher) were more likely to be late responders, meaning they needed more time to achieve significant weight loss
A comprehensive study of their pleiotropic effects may elucidate their function in addressing the other several facets of metabolic disorder, thereby justifying their high cost by preventing numerous problems
In rare cases, medications may trigger systemic inflammation, which may also affect the ocular surface and contribute to dry eye symptoms
